{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-09-03T10:12:53.490575+00:00","company":{"ticker":"RMTG","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc."},"pagination":{"limit":100,"returned":2,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"GHS","detail":"equity_purchase","count":1,"first_seen":"2023-12-13T23:59:59+00:00","last_seen":"2023-12-13T23:59:59+00:00","evidence_fact_ids":[88620]}]},"facts":[{"fact_type":"material_agreement","fact_key":"3bd00eab75e8ed2bb1f9a7cb562038bd974b738f","cik":1760026,"ticker":"RMTG","company_name":"Regenerative Medical Technology Group Inc.","filed_at":"2023-12-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Equity Financing Agreement","agreement_type":"equity_purchase","counterparty":"GHS","effective_date":"2023-12-08","item_codes_triggered":["1.01"],"value_text":"up to $10,000,000"},"claim":"Regenerative Medical Technology Group Inc. entered into Equity Financing Agreement with GHS valued at up to $10,000,000 (effective 2023-12-08).","evidence_excerpt":"On December 8, 2023, we entered into an Equity Financing Agreement (the “Financing Agreement”) and Registration Rights Agreement with GHS.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-095384","anchor_url":"https://secwatch.observer/filing/0001213900-23-095384#claim-3bd00eab75e8ed2bb1f9a7cb562038bd974b738f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760026/000121390023095384/0001213900-23-095384-index.htm"},{"fact_type":"auditor_change","fact_key":"d0b54e4de8c951aaff7d38171353f3c7297cd404","cik":1760026,"ticker":"RMTG","company_name":"Regenerative Medical Technology Group Inc.","filed_at":"2023-09-27T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"L J Soldinger Associates, LLC","disagreement_text":null,"effective_date":"2023-09-22","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"Victor Mokuolu, CPA PLLC"},"claim":"Regenerative Medical Technology Group Inc. dismissed L J Soldinger Associates, LLC as its auditor.","evidence_excerpt":"On September 22, 2023, we dismissed L J Soldinger Associates, LLC (the \"Former Accountant\") as our independent registered public accounting firm and, on September 22, 2023, we engaged Victor Mokuolu, CPA PLLC (the \"New Accountant\") as our independent registered public accounting firm.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-23-079657","anchor_url":"https://secwatch.observer/filing/0001213900-23-079657#claim-d0b54e4de8c951aaff7d38171353f3c7297cd404","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1760026/000121390023079657/0001213900-23-079657-index.htm"}]}